BioGaia AB (publ)
BGLAF
$10.24
-$0.18-1.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.19% | 8.00% | 8.41% | 9.91% | 7.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.19% | 8.00% | 8.41% | 9.91% | 7.27% |
| Cost of Revenue | 15.69% | 13.61% | 10.39% | 13.29% | 5.98% |
| Gross Profit | 10.93% | 6.02% | 7.69% | 8.68% | 7.73% |
| SG&A Expenses | 27.16% | 22.80% | 14.71% | 15.52% | 11.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.75% | 23.35% | 15.83% | 18.67% | 12.91% |
| Operating Income | 6.21% | -20.41% | -6.84% | -7.08% | -3.94% |
| Income Before Tax | -3.17% | -27.13% | -16.84% | -4.35% | -18.44% |
| Income Tax Expenses | -5.35% | -28.60% | -14.93% | -6.76% | -0.54% |
| Earnings from Continuing Operations | -2.56% | -26.72% | -17.36% | -3.67% | -22.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.56% | -26.72% | -17.36% | -3.67% | -22.37% |
| EBIT | 6.21% | -20.41% | -6.84% | -7.08% | -3.94% |
| EBITDA | -5.18% | -8.60% | 5.38% | 4.53% | 7.97% |
| EPS Basic | -2.72% | -26.83% | -17.43% | -3.69% | -22.37% |
| Normalized Basic EPS | -3.73% | -26.73% | -16.68% | -4.68% | -1.09% |
| EPS Diluted | -2.81% | -26.96% | -17.58% | -3.78% | -22.40% |
| Normalized Diluted EPS | -3.73% | -26.73% | -16.68% | -4.68% | -1.09% |
| Average Basic Shares Outstanding | 0.16% | 0.16% | 0.11% | 0.07% | 0.02% |
| Average Diluted Shares Outstanding | 0.15% | 0.15% | 0.12% | 0.08% | 0.03% |
| Dividend Per Share | 1.18% | 1.18% | 1.18% | 1.18% | 31.98% |
| Payout Ratio | 0.14% | 0.51% | 1.83% | 1.43% | 2.02% |